Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can better eating keep older stomach cancer patients stronger?

NCT ID NCT07176455

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study follows 438 older adults (60+) who had surgery for gastric cancer. Researchers want to understand how diet changes over time and how those changes relate to frailty. Participants complete surveys at discharge and at 1, 3, and 6 months after surgery. The goal is to design better dietary support to help these survivors stay healthier longer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Anti-frailty dietary behavior intervention
What this could lead to
If successful, this could lead to better dietary guidelines to reduce frailty in older gastric cancer survivors.
What could go wrong
This is an observational study with a behavioral intervention, not a drug trial. Results may not apply to all patients, and the follow-up is only 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 438 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing radical gastrectomy for gastric cancer at selected tertiary hospitals in Jiangsu Province between July 2025 and October 2026 were enrolled as study subjects. Discharge served as the baseline (T0), with follow-up surveys conducted at 1 month post-surgery (T1), 3 months post-surgery (T2), and 6 months post-surgery (T3).

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of gastric cancer; Performed the radical gastrectomy; Discharge within one month after surgery; Age ≥60 years old; Aware of personal diagnosis; Must be able to articulate views clearly; Voluntarily agree to participate in this study and sign the informed consent form. Exclusion Criteria: * Severe cardiac, hepatic, pulmonary, or renal insufficiency; Tumors in other sites.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty in adult surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nanjing Medical University

    Nanjing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.